Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?
- 28 February 1994
- journal article
- review article
- Published by Elsevier BV in Immunology Today
- Vol. 15 (2), 48-51
- https://doi.org/10.1016/0167-5699(94)90131-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon geneInternational Journal of Cancer, 1993
- Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.The Journal of Experimental Medicine, 1993
- Ultrastructural evidence of the mechanisms responsible for interleukin‐4‐activated rejection of a spontaneous murine adenocarcinomaInternational Journal of Cancer, 1993
- Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cellsInternational Journal of Cancer, 1993
- Macrophage colony‐stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppressionEuropean Journal of Immunology, 1993
- Reduced tumorigenicity of fibrosarcomas which constitutively generate il‐1α either spontaneously or following il‐1α gene transferInternational Journal of Cancer, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Interleukin 2‐dependent activation of tumor‐specific cytotoxic T lymphocytes in vivoEuropean Journal of Immunology, 1991
- Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL‐2 cDNAInternational Journal of Cancer, 1991
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990